ADVANCED PROTEOME THERAPEUTICS CORPORATION

Advanced Proteome Therapeutics Corporation

APC.H

CA0076282098

Investment Holding Companies

Delayed Toronto S.E. Other stock markets 02:25:53 05/12/2023 am IST			5-day change	1st Jan Change
0.005 ^CAD	-.--%		-.--%	-.--%

2023	Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	CI
2023	Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	CI

Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2020

November 01, 2020 at 03:58 am IST

Advanced Proteome Therapeutics Corporation announced earnings results for the full year ended July 31, 2020. For the full year, the company announced net loss was USD 450,636 compared to USD 333,466 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.

Latest news about Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	30/23/30	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	29/23/29	CI
Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp.	17/23/17	CI
Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital	23/22/23	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	22/22/22	CI
Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors	21/22/21	CI
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	15/22/15	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	15/22/15	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	29/22/29	CI
Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims	13/22/13	MT
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	25/22/25	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	17/21/17	CI
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	29/21/29	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	29/21/29	CI
Advanced Proteome Therapeutics Provides Update on COVID Program	24/21/24	MT
Advanced Proteome Therapeutics : Appoints Benjamin Krantz to CEO of US Subsidiary	21/21/21	MT
Advanced Proteome Therapeutics Announces Appointment of Benjamin Krantz to CEO	21/21/21	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter Ended April 30, 2021	30/21/30	CI
Advanced Proteome Therapeutics : Announces Senior Appointments	09/21/09	MT
Advanced Proteome Therapeutics Corporation Announces Appointment of New Scientific Advisory Board Member	09/21/09	CI
Advanced Proteome Therapeutics Corporation announced that it has received CAD 1.5 million in funding	13/21/13	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter Ended January 31, 2021	31/21/31	CI
Advanced Proteome Therapeutics : French second-hand car group Aramis eyeing IPO	08/21/08	RE
Advanced Proteome Therapeutics Corporation announced that it expects to receive CAD 1.25 million in funding	01/21/01	CI
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2020	30/20/30	CI

Chart Advanced Proteome Therapeutics Corporation

Duration

Period

Chart Advanced Proteome Therapeutics Corporation

More charts

Company Profile

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

Sector

Investment Holding Companies

Calendar

25/06/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
ADVANCED PROTEOME THERAPEUTICS CORPORATION	-.--%	2L
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+151.43%	661.36Cr
CHURCHILL CAPITAL CORP VII	+2.28%	98Cr
APPLE ISPORTS GROUP, INC.	+41.91%	87Cr
PERELLA WEINBERG PARTNERS	+33.52%	86Cr
ARES ACQUISITION CORPORATION II	+1.77%	66Cr
E7 GROUP	+2.33%	64Cr
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	60Cr
ADMIRAL ACQUISITION LIMITED	+3.61%	50Cr
CAPITOL INVESTMENT CORP. VII	-.--%	50Cr

Shell Companies